Health Resources Corporation makes and sells Intake, the most prescribed name-brand cholesterol-lowering medication. Jerichol Company has the potential to make a generic version of the same drug. Health Resources pays Jerichol not to sell its product. This is

Question

Quizplus · Accepted Answer

This scenario describes a "pay-for-delay" agreement, which is a form of price-fixing where a brand-name drug manufacturer pays a potential generic competitor to delay entering the market, thus maintaining higher prices.

Health Resources Corporation Makes and Sells Intake, the Most Prescribed